These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 33188942)

  • 1. Osteoclastogenesis and sphingosine-1-phosphate secretion from human osteoclast precursor monocytes are modulated by the cystic fibrosis transmembrane conductance regulator.
    Jourdain ML; Sergheraert J; Braux J; Guillaume C; Gangloff SC; Hubert D; Velard F; Jacquot J
    Biochim Biophys Acta Mol Basis Dis; 2021 Mar; 1867(3):166010. PubMed ID: 33188942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis.
    Le Henaff C; Haÿ E; Velard F; Marty C; Tabary O; Marie PJ; Jacquot JP
    Am J Pathol; 2014 Apr; 184(4):1132-1141. PubMed ID: 24529904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation.
    Le Henaff C; Gimenez A; Haÿ E; Marty C; Marie P; Jacquot J
    Am J Pathol; 2012 May; 180(5):2068-75. PubMed ID: 22449949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correction of lung inflammation in a F508del CFTR murine cystic fibrosis model by the sphingosine-1-phosphate lyase inhibitor LX2931.
    Veltman M; Stolarczyk M; Radzioch D; Wojewodka G; De Sanctis JB; Dik WA; Dzyubachyk O; Oravecz T; de Kleer I; Scholte BJ
    Am J Physiol Lung Cell Mol Physiol; 2016 Nov; 311(5):L1000-L1014. PubMed ID: 27663991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the cystic fibrosis mutation F508del-CFTR on renal cyst formation and growth.
    Li H; Yang W; Mendes F; Amaral MD; Sheppard DN
    Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1176-86. PubMed ID: 22874761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unravelling the Regions of Mutant F508del-CFTR More Susceptible to the Action of Four Cystic Fibrosis Correctors.
    Amico G; Brandas C; Moran O; Baroni D
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31683989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of CFTR function in patients with cystic fibrosis carrying the F508del-CFTR mutation.
    De Stefano D; Villella VR; Esposito S; Tosco A; Sepe A; De Gregorio F; Salvadori L; Grassia R; Leone CA; De Rosa G; Maiuri MC; Pettoello-Mantovani M; Guido S; Bossi A; Zolin A; Venerando A; Pinna LA; Mehta A; Bona G; Kroemer G; Maiuri L; Raia V
    Autophagy; 2014; 10(11):2053-74. PubMed ID: 25350163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurements of Functional Responses in Human Primary Lung Cells as a Basis for Personalized Therapy for Cystic Fibrosis.
    Awatade NT; Uliyakina I; Farinha CM; Clarke LA; Mendes K; Solé A; Pastor J; Ramos MM; Amaral MD
    EBioMedicine; 2015; 2(2):147-53. PubMed ID: 26137539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two Small Molecules Restore Stability to a Subpopulation of the Cystic Fibrosis Transmembrane Conductance Regulator with the Predominant Disease-causing Mutation.
    Meng X; Wang Y; Wang X; Wrennall JA; Rimington TL; Li H; Cai Z; Ford RC; Sheppard DN
    J Biol Chem; 2017 Mar; 292(9):3706-3719. PubMed ID: 28087700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anion transporter SLC26A9 localizes to tight junctions and is degraded by the proteasome when co-expressed with F508del-CFTR.
    Sato Y; Thomas DY; Hanrahan JW
    J Biol Chem; 2019 Nov; 294(48):18269-18284. PubMed ID: 31645438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteoblast CFTR inactivation reduces differentiation and osteoprotegerin expression in a mouse model of cystic fibrosis-related bone disease.
    Stalvey MS; Clines KL; Havasi V; McKibbin CR; Dunn LK; Chung WJ; Clines GA
    PLoS One; 2013; 8(11):e80098. PubMed ID: 24236172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Levels of the Bioactive Sphingolipid Metabolite S1P in Adult Cystic Fibrosis Patients: Potential Target for Immunonutrition?
    Halilbasic E; Fuerst E; Heiden D; Japtok L; Diesner SC; Trauner M; Kulu A; Jaksch P; Hoetzenecker K; Kleuser B; Kazemi-Shirazi L; Untersmayr E
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32183316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. F508del-CFTR increases intracellular Ca(2+) signaling that causes enhanced calcium-dependent Cl(-) conductance in cystic fibrosis.
    Martins JR; Kongsuphol P; Sammels E; Dahimène S; Aldehni F; Clarke LA; Schreiber R; de Smedt H; Amaral MD; Kunzelmann K
    Biochim Biophys Acta; 2011 Nov; 1812(11):1385-92. PubMed ID: 21907281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation.
    Blanchard E; Marie S; Riffault L; Bonora M; Tabary O; Clement A; Jacquot J
    Biochem Biophys Res Commun; 2011 Aug; 411(3):471-6. PubMed ID: 21723850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity.
    Malik FA; Meissner A; Semenkov I; Molinski S; Pasyk S; Ahmadi S; Bui HH; Bear CE; Lidington D; Bolz SS
    PLoS One; 2015; 10(6):e0130313. PubMed ID: 26079370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystic fibrosis F508del patients have apically localized CFTR in a reduced number of airway cells.
    Penque D; Mendes F; Beck S; Farinha C; Pacheco P; Nogueira P; Lavinha J; Malhó R; Amaral MD
    Lab Invest; 2000 Jun; 80(6):857-68. PubMed ID: 10879737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The major cystic fibrosis causing mutation exhibits defective propensity for phosphorylation.
    Pasyk S; Molinski S; Ahmadi S; Ramjeesingh M; Huan LJ; Chin S; Du K; Yeger H; Taylor P; Moran MF; Bear CE
    Proteomics; 2015 Jan; 15(2-3):447-61. PubMed ID: 25330774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solubilizing mutations used to crystallize one CFTR domain attenuate the trafficking and channel defects caused by the major cystic fibrosis mutation.
    Pissarra LS; Farinha CM; Xu Z; Schmidt A; Thibodeau PH; Cai Z; Thomas PJ; Sheppard DN; Amaral MD
    Chem Biol; 2008 Jan; 15(1):62-9. PubMed ID: 18215773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ORKAMBI-Mediated Rescue of Mucociliary Clearance in Cystic Fibrosis Primary Respiratory Cultures Is Enhanced by Arginine Uptake, Arginase Inhibition, and Promotion of Nitric Oxide Signaling to the Cystic Fibrosis Transmembrane Conductance Regulator Channel.
    Wu YS; Jiang J; Ahmadi S; Lew A; Laselva O; Xia S; Bartlett C; Ip W; Wellhauser L; Ouyang H; Gonska T; Moraes TJ; Bear CE
    Mol Pharmacol; 2019 Oct; 96(4):515-525. PubMed ID: 31427400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis mice.
    Dhooghe B; Noël S; Bouzin C; Behets-Wydemans G; Leal T
    PLoS One; 2013; 8(10):e77314. PubMed ID: 24204804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.